Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis

Clinical trial NCT00289978 · COMPLETED

Trial details

NCT number: NCT00289978
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing-remitting Multiple Sclerosis

Start date: 2006-01-01
Primary completion: 2009-07-01
Enrollment: 1272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.